Cannabinoid Receptor-2 Ameliorates Inflammation in Crohn’s Disease
This article originally appeared at https://academic.oup.com/ecco-jcc/article/11/11/1369/3977952?login=false Abstract Background and Aims Cannabinoid receptor stimulation may have positive symptomatic effects on inflammatory bowel disease [IBD] patients through analgesic and anti-inflammatory effects. The cannabinoid 2 receptor [CB2R] is expressed primarily on immune cells, including CD4+ T cells, and is induced by active inflammation in both humans and mice. […]
